Mirikizumab trials for Crohn's disease

All Mirikizumab trials · All Crohn's disease trials

Phase breakdown

Recruiting trials studying Mirikizumab for Crohn's disease

• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
  NCT04844606 · Phase: Phase 3 · Ages: 2 Years to 19 Years · Sex: All (male and female) · 136 locations
• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
  NCT05509777 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 81 locations
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 183 locations
• Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
  NCT06997965 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many trials study Mirikizumab for Crohn's disease?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.